Viewing StudyNCT04364230



Ignite Creation Date: 2024-05-06 @ 2:36 PM
Last Modification Date: 2024-10-26 @ 1:33 PM
Study NCT ID: NCT04364230
Status: COMPLETED
Last Update Posted: 2023-10-11
First Post: 2020-04-21

Brief Title: Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma Including Ocular Melanoma
Sponsor: Craig L Slingluff Jr
Organization: University of Virginia

Conditions & Keywords Data

Conditions:
Name
Uveal Melanoma
Melanoma
Ocular Melanoma
Keywords:
Name View
Uveal Melanoma View
peptide View
vaccine View
6MHP View
adjuvant View
polyICLC View
CDX-1140 View
NeoAg-mBRAF View
CD40 View
TLR View
nevi View
nevus View
BRAF585-614-V600E View
Ocular Melanoma View